Literature DB >> 18698016

Targets of tumor immunity after allogeneic hematopoietic stem cell transplantation.

Yishay Ofran1, Jerome Ritz.   

Abstract

The effectiveness of allogeneic hematopoietic stem cell transplantation for hematologic malignancies results from the donor immunity to antigens expressed in leukemia cells in the recipient. Similar immune responses have now been identified in patients with renal cell cancer with tumor regression after allogeneic hematopoietic stem cell transplantation. Further studies to identify relevant antigens and mechanisms of resistance may improve the effectiveness of this approach in patients with solid tumors.

Entities:  

Mesh：

Year:  2008        PMID： 18698016      PMCID： PMC2586881          DOI： 10.1158/1078-0432.CCR-08-0857

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  12 in total

Review 1.  Induction of tumor immunity following allogeneic stem cell transplantation.

Authors:  Catherine J Wu; Jerome Ritz
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

2.  Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.

Authors:  David B Miklos; Haesook T Kim; Katherine H Miller; Luxuan Guo; Emmanuel Zorn; Stephanie J Lee; Ephraim P Hochberg; Catherine J Wu; Edwin P Alyea; Corey Cutler; Vincent Ho; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2004-12-21       Impact factor: 22.113

3.  Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia.

Authors:  J J Molldrem; P P Lee; C Wang; K Felio; H M Kantarjian; R E Champlin; M M Davis
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

4.  Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia.

Authors:  C J Wu; X F Yang; S McLaughlin; D Neuberg; C Canning; B Stein; E P Alyea; R J Soiffer; G Dranoff; J Ritz
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 5.  Immunosuppressive strategies that are mediated by tumor cells.

Authors:  Gabriel A Rabinovich; Dmitry Gabrilovich; Eduardo M Sotomayor
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

6.  Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.

Authors:  Scott S Tykodi; Edus H Warren; John A Thompson; Stanley R Riddell; Richard W Childs; Brith E Otterud; Mark F Leppert; Rainer Storb; Brenda M Sandmaier
Journal:  Clin Cancer Res       Date:  2004-12-01       Impact factor: 12.531

7.  Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells.

Authors:  Yoshiyuki Takahashi; Nanae Harashima; Sachiko Kajigaya; Hisayuki Yokoyama; Elena Cherkasova; J Philip McCoy; Ken-Ichi Hanada; Othon Mena; Roger Kurlander; Abdul Tawab; Tawab Abdul; Ramaprasad Srinivasan; Andreas Lundqvist; Elizabeth Malinzak; Nancy Geller; Michael I Lerman; Richard W Childs
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

8.  C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.

Authors:  Scott S Tykodi; Nobuharu Fujii; Nathalie Vigneron; Sharon M Lu; Jeffrey K Mito; Maureen X Miranda; Jeffrey Chou; Lilien N Voong; John A Thompson; Brenda M Sandmaier; Peter Cresswell; Benoît Van den Eynde; Stanley R Riddell; Edus H Warren
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

Review 9.  Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions.

Authors:  Yoshiki Akatsuka; Yasuo Morishima; Kiyotaka Kuzushima; Yoshihisa Kodera; Toshitada Takahashi
Journal:  Cancer Sci       Date:  2007-05-22       Impact factor: 6.716

10.  A human minor histocompatibility antigen resulting from differential expression due to a gene deletion.

Authors:  Makoto Murata; Edus H Warren; Stanley R Riddell
Journal:  J Exp Med       Date:  2003-05-12       Impact factor: 14.307
View more
  8 in total

1.  Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice.

Authors:  Christopher A Klebanoff; Luca Gattinoni; Douglas C Palmer; Pawel Muranski; Yun Ji; Christian S Hinrichs; Zachary A Borman; Sid P Kerkar; Christopher D Scott; Steven E Finkelstein; Steven A Rosenberg; Nicholas P Restifo
Journal:  Clin Cancer Res       Date:  2011-07-07       Impact factor: 12.531

2.  Angiogenic cytokines are antibody targets during graft-versus-leukemia reactions.

Authors:  Matthias Piesche; Vincent T Ho; Haesook Kim; Yukoh Nakazaki; Michael Nehil; Nasser K Yaghi; Dmitriy Kolodin; Jeremy Weiser; Peter Altevogt; Helena Kiefel; Edwin P Alyea; Joseph H Antin; Corey Cutler; John Koreth; Christine Canning; Jerome Ritz; Robert J Soiffer; Glenn Dranoff
Journal:  Clin Cancer Res       Date:  2014-12-23       Impact factor: 12.531

Review 3.  Antigen Discovery and Therapeutic Targeting in Hematologic Malignancies.

Authors:  David A Braun; Catherine J Wu
Journal:  Cancer J       Date:  2017 Mar/Apr       Impact factor: 3.360

Review 4.  Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer.

Authors:  Robert R Jenq; Marcel R M van den Brink
Journal:  Nat Rev Cancer       Date:  2010-02-19       Impact factor: 60.716

5.  Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation.

Authors:  Vincent T Ho; Matthew Vanneman; Haesook Kim; Tetsuro Sasada; Yoon Joong Kang; Mildred Pasek; Corey Cutler; John Koreth; Edwin Alyea; Stefanie Sarantopoulos; Joseph H Antin; Jerome Ritz; Christine Canning; Jeffery Kutok; Martin C Mihm; Glenn Dranoff; Robert Soiffer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-26       Impact factor: 11.205

Review 6.  Post-transplantation cyclophosphamide to facilitate HLA-haploidentical hematopoietic cell transplantation: Mechanisms and results.

Authors:  Hany Elmariah; Ephraim J Fuchs
Journal:  Semin Hematol       Date:  2018-09-20       Impact factor: 3.754

7.  [The systemic evaluation and clinical significance of immunological function for advanced lung cancer patients].

Authors:  Tuya Wulan; Shiyong Wang; Weili Du; Hui Zhang; Yuan Zhang; Xue Zeng; Sa Liu; Yanping Liu; Lu Zhang; Zhe Zhang; Ying He; Jialing Wang; Xiuyan Wu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-04

Review 8.  Immune Reconstitution after Haploidentical Donor and Umbilical Cord Blood Allogeneic Hematopoietic Cell Transplantation.

Authors:  Hany Elmariah; Claudio G Brunstein; Nelli Bejanyan
Journal:  Life (Basel)       Date:  2021-01-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.